Capital Markets Day update
Creo Medical Group PLC announced that its Capital Markets Day, originally scheduled for Thursday, October 9th, will be postponed to a later date. The rearrangement is due to a scheduling conflict involving a keynote speaker who is now required to perform a lung tumour ablation case on the same day. A further announcement regarding the rescheduled date and arrangements for the Capital Markets Day will be released in due course.
Select text to share a quote on X · sign in to keep highlights & notes in your CREO notes
Creo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients, announces that the Company's Capital Markets Day, due to take place on Thursday 9 October, will be rearranged for later in the year as a scheduling conflict has arisen with a keynote speaker who now has a lung tumour ablation case on the same date. Given the significance of this clinician's activity within Creo's clinical programme and, more importantly, the patient's clinical need, the Board have decided to rearrange the Capital Markets Day.
A further announcement relating to the new date and arrangements for the Capital Markets Day will be published in due course.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.